Repare Therapeutics
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
| Revenue | $52,404 | $13,047 | $2,159 | $30,249 |
| Gross Profit | 51,903 | 12,541 | 1,110 | 29,198 |
| EBITDA | 11,317 | -29,945 | -38,378 | -11,711 |
| EBIT | 10,816 | -30,451 | -38,876 | -12,217 |
| Net Income | 13,162 | -28,030 | -18,879 | -11,946 |
| Net Change In Cash | 52,404 | 13,047 | 2,159 | 30,249 |
| Free Cash Flow | 11,932 | -28,554 | -32,870 | -35,411 |
| Cash | 103,217 | 111,268 | 107,369 | 115,544 |
| Basic Shares | 44,024 | 42,139 | 42,102 | 42,089 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Revenue | $51,133 | $131,830 | $7,600 | $135 |
| Gross Profit | 49,182 | 127,646 | 4,256 | -1,652 |
| EBITDA | -112,809 | -20,104 | -108,516 | -53,638 |
| EBIT | -114,760 | -19,796 | -108,660 | -54,302 |
| Net Income | -93,796 | -29,047 | -106,908 | -53,417 |
| Net Change In Cash | 51,133 | 131,830 | 7,600 | 135 |
| Cost of Revenue | 8,085 | 231,995 | ||
| Free Cash Flow | -129,096 | -280 | -87,486 | -8,321 |
| Cash | 111,268 | 159,521 | 334,427 | 326,184 |
| Basic Shares | 42,093 | 41,922 | 37,818 | 36,902 |
Earnings Calls
| Quarter | EPS |
|---|---|
| 2024-03-31 | $0.30 |
| 2023-12-31 | -$0.67 |
| 2023-09-30 | -$0.45 |
| 2023-06-30 | -$0.28 |
